Pharming Group N.V.

ENXTAM:PHARM 株式レポート

時価総額:€500.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Pharming Group マネジメント

マネジメント 基準チェック /04

主要情報

Simon de Vries

最高経営責任者

US$2.8m

報酬総額

CEO給与比率24.0%
CEO在任期間15.6yrs
CEOの所有権2.1%
経営陣の平均在職期間3.3yrs
取締役会の平均在任期間3.3yrs

経営陣の近況

Recent updates

Revenues Working Against Pharming Group N.V.'s (AMS:PHARM) Share Price

Feb 14
Revenues Working Against Pharming Group N.V.'s (AMS:PHARM) Share Price

Health Check: How Prudently Does Pharming Group (AMS:PHARM) Use Debt?

Nov 11
Health Check: How Prudently Does Pharming Group (AMS:PHARM) Use Debt?

Pharming Group N.V. (AMS:PHARM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Aug 23
Pharming Group N.V. (AMS:PHARM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Health Check: How Prudently Does Pharming Group (AMS:PHARM) Use Debt?

Jun 20
Health Check: How Prudently Does Pharming Group (AMS:PHARM) Use Debt?

Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Mar 16
Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 41% Above Its Share Price

Feb 17
Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 41% Above Its Share Price

We Think Pharming Group (AMS:PHARM) Can Manage Its Debt With Ease

Dec 08
We Think Pharming Group (AMS:PHARM) Can Manage Its Debt With Ease

Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Aug 05
Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Pharming Group N.V. Just Missed EPS By 56%: Here's What Analysts Think Will Happen Next

Mar 21
Pharming Group N.V. Just Missed EPS By 56%: Here's What Analysts Think Will Happen Next

These Analysts Think Pharming Group N.V.'s (AMS:PHARM) Sales Are Under Threat

Mar 19
These Analysts Think Pharming Group N.V.'s (AMS:PHARM) Sales Are Under Threat

Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Feb 20
Is Pharming Group (AMS:PHARM) Using Too Much Debt?

Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 40% Above Its Share Price

Oct 29
Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 40% Above Its Share Price

Pharming Group (AMS:PHARM) Seems To Use Debt Quite Sensibly

Jun 03
Pharming Group (AMS:PHARM) Seems To Use Debt Quite Sensibly

Increases to CEO Compensation Might Be Put On Hold For Now at Pharming Group N.V. (AMS:PHARM)

May 12
Increases to CEO Compensation Might Be Put On Hold For Now at Pharming Group N.V. (AMS:PHARM)

Is Pharming Group N.V.'s (AMS:PHARM) Recent Performance Tethered To Its Attractive Financial Prospects?

Mar 15
Is Pharming Group N.V.'s (AMS:PHARM) Recent Performance Tethered To Its Attractive Financial Prospects?

CEO報酬分析

Pharming Group の収益と比較して、Simon de Vries の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$11m

Dec 31 2023US$3mUS$673k

-US$11m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$2m

Dec 31 2022US$2mUS$636k

US$14m

Sep 30 2022n/an/a

US$30m

Jun 30 2022n/an/a

US$21m

Mar 31 2022n/an/a

US$11m

Dec 31 2021US$3mUS$681k

US$16m

Sep 30 2021n/an/a

US$22m

Jun 30 2021n/an/a

US$31m

Mar 31 2021n/an/a

US$37m

Dec 31 2020US$3mUS$614k

US$38m

Sep 30 2020n/an/a

US$44m

Jun 30 2020n/an/a

US$46m

Mar 31 2020n/an/a

US$42m

Jan 01 2020n/an/a

US$41m

Sep 30 2019n/an/a

US$38m

Jun 30 2019n/an/a

US$34m

Mar 31 2019n/an/a

US$29m

Dec 31 2018US$2mUS$579k

US$29m

Sep 30 2018n/an/a

-US$29m

Jun 30 2018n/an/a

-US$44m

Mar 31 2018n/an/a

-US$80m

Dec 31 2017US$2mUS$537k

-US$91m


CEO(最高経営責任者

Simon de Vries (65 yo)

15.6yrs

在職期間

US$2,809,000

報酬

Dr. Sijmen De Vries, also known as Simon, M. D., M. B.A., has been the Chief Executive Officer of Pharming Group N. V. since November 03, 2008 and also serves as its Executive Director since October 13, 20...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Sijmen de Vries
President15.6yrsUS$2.81m2.15%
$ 10.7m
Jeroen Wakkerman
Chief Financial Officer3.6yrsデータなし0.064%
$ 320.1k
Mireille Sanders
Chief Operations Officer4.8yrsデータなし0.12%
$ 593.7k
Susanne Embleton
Investor Relations Managerno dataデータなしデータなし
Ruud Van Outersterp
Chief Ethics & Compliance Officer3.1yrsデータなし0.025%
$ 122.7k
Anurag Relan
Chief Medical Officer3yrsデータなし0.027%
$ 136.9k
Stephen Toor
Chief Commercial Officer & GM Americas7.4yrsデータなし0.028%
$ 139.5k
Alexander Breidenbach
Chief Business Officerless than a yearデータなし0.0097%
$ 48.5k
Bruno M. Giannetti
Consultant3yrsデータなしデータなし

3.3yrs

平均在職期間

58yo

平均年齢


取締役

名称ポジション在職期間報酬所有権
Sijmen de Vries
President15.7yrsUS$2.81m2.15%
$ 10.7m
Leonard Kruimer
Independent Non-Executive Director3.1yrsUS$90.00k0.015%
$ 77.5k
Mark Pykett
Independent Non-Executive Director3.5yrsUS$87.00k0.019%
$ 95.9k
Deborah Jorn
Independent Non-Executive Vice-Chairperson5.1yrsUS$87.00k0.021%
$ 107.5k
Steven Baert
Independent Non-Executive Director3.1yrsUS$90.00k0.015%
$ 77.5k
Barbara Yanni
Independent Non-Executive Director3.5yrsUS$94.00k0.019%
$ 95.9k
Richard Peters
Non-Executive Chairman of Boardless than a yearUS$46.00k0.0060%
$ 29.9k
Jabine van der Meijs
Independent Non-Executive Director3.1yrsUS$94.00k0.015%
$ 77.5k

3.3yrs

平均在職期間

63yo

平均年齢